Hyperacute Management of Ischemic Stroke

Abstract

Stroke is a devastating disease and currently the fourth leading cause of death in this country. Acute ischemic stroke is an emergency and requires effective triage, diagnosis, and critical management. The hyperacute management of ischemic stroke begins in the field, with recognition of stroke symptoms by emergency medical systems (EMS) personnel. The EMS is an important component to an effective stroke system of care, which also includes primary stroke centers, routing protocols for acute ischemic stroke, and telemedicine. Following the arrival of a potential stroke patient to the emergency room setting, patients should be stabilized and undergo assessment for potential intravenous alteplase (IV tPA) treatment. Assessments include diagnostic tests, neuroimaging, and standardized stroke evaluations. After these assessments have been performed, IV tPA, the only medication for acute stroke approved by the U.S. Food and Drug Administration, can be considered using a variety of inclusion and exclusion criteria. Previously time restrictions limited the usage of IV tPA to 3 hours, but this time window has now been extended for eligible candidates to 4.5 hours. The administration of IV tPA has specific requirements for monitoring and should be standardized via protocol across hospitals.

Keywords

acute ischemic stroke - stroke systems of care

• References

• 1 Towfighi A, Saver JL. Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke 2011; 42 (8) 2351-2355
• 2 Fonarow GC, Gregory T, Driskill M , et al. Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes. Circulation 2010; 122 (23) 2459-2469
• 3 Schwamm LH, Pancioli A, Acker III JE , et al; American Stroke Association's Task Force on the Development of Stroke Systems. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation 2005; 111 (8) 1078-1091
• 4 Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press;
• 5 H.R. 3658. Stroke Treatment and Ongoing Prevention Act (STOP Stroke Act). Enacted June 14, 2004
• 6 Alberts MJ, Hademenos G, Latchaw RE , et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283 (23) 3102-3109
• 7 Alberts MJ, Latchaw RE, Jagoda A , et al; Brain Attack Coalition. Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition. Stroke 2011; 42 (9) 2651-2665
• 8 Song S, Saver J. Growth of regional acute stroke systems of care in the United States in the first decade of the 21st century. Stroke 2012; 43 (7) 1975-1978
• 9 Xian Y, Holloway RG, Chan PS , et al. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA 2011; 305 (4) 373-380
• 10 Meretoja A, Roine RO, Kaste M , et al. Effectiveness of primary and comprehensive stroke centers: PERFECT stroke: a nationwide observational study from Finland. Stroke 2010; 41 (6) 1102-1107
• 11 Higashida R, Alberts MJ, Alexander DN , et al; American Heart Association Advocacy Coordinating Committee. Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke 2013; 44 (10) 2961-2984
• 12 Rost NS, Smith EE, Pervez MA, Mello P, Dreyer P, Schwamm LH. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program. Circ Cardiovasc Qual Outcomes 2012; 5 (3) 314-320
• 13 Alberts MJ, Latchaw RE, Selman WR , et al; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005; 36 (7) 1597-1616
• 14 Schuberg S, Song S, Saver JL, Mack WJ, Cen SY, Sanossian N. Impact of emergency medical services stroke routing protocols on primary stroke center certification in California. Stroke 2013; 44 (12) 3584-3586
• 15 Prabhakaran S, O'Neill K, Stein-Spencer L, Walter J, Alberts MJ. Prehospital triage to primary stroke centers and rate of stroke thrombolysis. JAMA Neurol 2013; 70 (9) 1126-1132
• 16 Rosamond WD, Gorton RA, Hinn AR, Hohenhaus SM, Morris DL. Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Acad Emerg Med 1998; 5 (1) 45-51
• 17 Acker III JE, Pancioli AM, Crocco TJ , et al; American Heart Association; American Stroke Association Expert Panel on Emergency Medical Services Systems, Stroke Council. Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke 2007; 38 (11) 3097-3115
• 18 Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000; 31 (1) 71-76
• 19 Morgenstern LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med 2003; 163 (18) 2198-2202
• 20 McKinney JS, Mylavarapu K, Lane J, Roberts V, Ohman-Strickland P, Merlin MA. Hospital prenotification of stroke patients by emergency medical services improves stroke time targets. J Stroke Cerebrovasc Dis 2013; 22 (2) 113-118
• 21 Kim SK, Lee SY, Bae HJ , et al. Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke. Eur J Neurol 2009; 16 (12) 1331-1335
• 22 Patel MD, Rose KM, O'Brien EC, Rosamond WD. Prehospital notification by emergency medical services reduces delays in stroke evaluation: findings from the North Carolina stroke care collaborative. Stroke 2011; 42 (8) 2263-2268
• 23 Levine SR, Gorman M. “Telestroke” : the application of telemedicine for stroke. Stroke 1999; 30 (2) 464-469
• 24 Thrall JH. Teleradiology. Part I. History and clinical applications. Radiology 2007; 243 (3) 613-617
• 25 Schwab S, Vatankhah B, Kukla C , et al; TEMPiS Group. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007; 69 (9) 898-903
• 26 Pervez MA, Silva G, Masrur S , et al. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke 2010; 41 (1) e18-e24
• 27 Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ. The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology 2011; 77 (17) 1590-1598
• 28 Bergrath S, Rörtgen D, Rossaint R , et al. Technical and organisational feasibility of a multifunctional telemedicine system in an emergency medical service - an observational study. J Telemed Telecare 2011; 17 (7) 371-377
• 29 Jauch EC, Saver JL, Adams Jr HP , et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44 (3) 870-947
• 30 Schwamm LH, Pancioli A, Acker III JE , et al; American Stroke Association's Task Force on the Development of Stroke Systems. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke 2005; 36 (3) 690-703
• 31 Allen NB, Myers D, Watanabe E , et al. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?. Cerebrovasc Dis 2009; 27 (3) 254-258
• 32 Chernyshev OY, Martin-Schild S, Albright KC , et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010; 74 (17) 1340-1345
• 33 Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke 2009; 40 (7) 2507-2511
• 34 Frankel MR, Morgenstern LB, Kwiatkowski T , et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 2000; 55 (7) 952-959
• 35 Rost NS, Masrur S, Pervez MA, Viswanathan A, Schwamm LH. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology 2009; 73 (23) 1957-1962
• 36 Kerr G, Ray G, Wu O, Stott DJ, Langhorne P. Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 2009; 28 (3) 220-226
• 37 Goldstein LB. Stroke code chest radiographs are not useful. Cerebrovasc Dis 2007; 24 (5) 460-462
• 38 Moulin T, Cattin F, Crépin-Leblond T , et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 1996; 47 (2) 366-375
• 39 Leary MC, Kidwell CS, Villablanca JP , et al. Validation of computed tomographic middle cerebral artery “dot”sign: an angiographic correlation study. Stroke 2003; 34 (11) 2636-2640
• 40 Patel SC, Levine SR, Tilley BC , et al; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 286 (22) 2830-2838
• 41 Barber PA, Darby DG, Desmond PM , et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 1999; 30 (10) 2059-2065
• 42 Kidwell CS, Saver JL, Villablanca JP , et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002; 33 (1) 95-98
• 43 Kakuda W, Thijs VN, Lansberg MG , et al; DEFUSE Investigators. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005; 65 (8) 1175-1178
• 44 Wojner-Alexander AW, Garami Z, Chernyshev OY, Alexandrov AV. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 2005; 64 (8) 1354-1357
• 45 Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin 2008; 26 (2) 521-541, x x.
• 46 Prasad K, Krishnan PR. Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis. Acta Neurol Scand 2010; 122 (6) 404-408
• 47 den Hertog HM, van der Worp HB, van Gemert HM , et al; PAIS Investigators. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009; 8 (5) 434-440
• 48 Den Hertog HM, van der Worp HB, Tseng MC, Dippel DW. Cooling therapy for acute stroke. Cochrane Database Syst Rev 2009; (1) CD001247
• 49 Adams Jr HP, del Zoppo G, Alberts MJ , et al; American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association Clinical Cardiology Council; American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease Working Group; Quality of Care Outcomes in Research Interdisciplinary Working Group. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115 (20) e478-e534
• 50 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333 (24) 1581-1587
• 51 Kwiatkowski TG, Libman RB, Frankel M , et al; National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999; 340 (23) 1781-1787
• 52 Marler JR, Tilley BC, Lu M , et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000; 55 (11) 1649-1655
• 53 Fonarow GC, Smith EE, Saver JL , et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 2011; 123 (7) 750-758
• 54 Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009; 40 (6) 2079-2084
• 55 Hacke W, Donnan G, Fieschi C , et al; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363 (9411) 768-774
• 56 Hacke W, Kaste M, Bluhmki E , et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 (13) 1317-1329
• 57 Wahlgren N, Ahmed N, Dávalos A , et al; SITS investigators. Thrombolysis with alteplase 3-4.5.  h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372 (9646) 1303-1309
• 58 Del Zoppo GJ, Saver JL, Jauch EC, Adams Jr HP ; American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40 (8) 2945-2948
• 59 Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005; 36 (11) 2497-2499
• 60 Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 1997; 28 (11) 2109-2118
• 61 Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM ; Cleveland Clinic Health System Stroke Quality Improvement Team. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003; 34 (3) 799-800
• 62 Hill MD, Lye T, Moss H , et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003; 60 (9) 1525-1527